» Articles » PMID: 29142010

Value of Progression of Coronary Artery Calcification for Risk Prediction of Coronary and Cardiovascular Events: Result of the HNR Study (Heinz Nixdorf Recall)

Abstract

Background: Computed tomography (CT) allows estimation of coronary artery calcium (CAC) progression. We evaluated several progression algorithms in our unselected, population-based cohort for risk prediction of coronary and cardiovascular events.

Methods: In 3281 participants (45-74 years of age), free from cardiovascular disease until the second visit, risk factors, and CTs at baseline (b) and after a mean of 5.1 years (5y) were measured. Hard coronary and cardiovascular events, and total cardiovascular events including revascularization, as well, were recorded during a follow-up time of 7.8±2.2 years after the second CT. The added predictive value of 10 CAC progression algorithms on top of risk factors including baseline CAC was evaluated by using survival analysis, C-statistics, net reclassification improvement, and integrated discrimination index. A subgroup analysis of risk in CAC categories was performed.

Results: We observed 85 (2.6%) hard coronary, 161 (4.9%) hard cardiovascular, and 241 (7.3%) total cardiovascular events. Absolute CAC progression was higher with versus without subsequent coronary events (median, 115 [Q1-Q3, 23-360] versus 8 [0-83], <0.0001; similar for hard/total cardiovascular events). Some progression algorithms added to the predictive value of baseline CT and risk assessment in terms of C-statistic or integrated discrimination index, especially for total cardiovascular events. However, CAC progression did not improve models including CAC and 5-year risk factors. An excellent prognosis was found for 921 participants with double-zero CAC=CAC=0 (10-year coronary and hard/total cardiovascular risk: 1.4%, 2.0%, and 2.8%), which was for participants with incident CAC 1.8%, 3.8%, and 6.6%, respectively. When CAC progressed from 1 to 399 to CAC≥400, coronary and total cardiovascular risk were nearly 2-fold in comparison with subjects who remained below CAC=400. Participants with CAC≥400 had high rates of hard coronary and hard/total cardiovascular events (10-year risk: 12.0%, 13.5%, and 30.9%, respectively).

Conclusions: CAC progression is associated with coronary and cardiovascular event rates, but adds only weakly to risk prediction. What counts is the most recent CAC value and risk factor assessment. Therefore, a repeat scan >5 years after the first scan may be of additional value, except when a double-zero CT scan is present or when the subjects are already at high risk.

Citing Articles

Significance of Coronary Artery Calcifications and Ischemic Electrocardiographic Changes Among Patients Undergoing Myocardial Perfusion Imaging.

Kokkinidis D, Kyriakoulis I, Chui P, Agarwal R, Liu Y, Khera R JACC Adv. 2025; 4(3):101618.

PMID: 39983619 PMC: 11891677. DOI: 10.1016/j.jacadv.2025.101618.


Updates on CAD risk assessment: using the coronary artery calcium score in combination with traditional risk factors.

Rezaie-Kalamtari K, Norouzi Z, Salmanipour A, Mehrali H Egypt Heart J. 2025; 77(1):14.

PMID: 39847250 PMC: 11757844. DOI: 10.1186/s43044-025-00608-4.


Understanding Vascular Calcification in Chronic Kidney Disease: Pathogenesis and Therapeutic Implications.

Siracusa C, Carabetta N, Morano M, Manica M, Strangio A, Sabatino J Int J Mol Sci. 2024; 25(23).

PMID: 39684805 PMC: 11642360. DOI: 10.3390/ijms252313096.


Relationship Between Dietary Inflammatory Index and Carotid Artery Calcification in Patients with Ischemic Stroke.

Jia X, Peng M, Wang Z, Li X, Mou T, Wang X J Inflamm Res. 2024; 17:10131-10140.

PMID: 39634286 PMC: 11616426. DOI: 10.2147/JIR.S479965.


Enhancing coronary artery plaque analysis via artificial intelligence-driven cardiovascular computed tomography.

Xia J, Bachour K, Suleiman A, Roberts J, Sayed S, Cho G Ther Adv Cardiovasc Dis. 2024; 18:17539447241303399.

PMID: 39625215 PMC: 11615974. DOI: 10.1177/17539447241303399.


References
1.
Liang C, Budoff M, Kaufman J, Kronmal R, Brown E . An alternative method for quantifying coronary artery calcification: the multi-ethnic study of atherosclerosis (MESA). BMC Med Imaging. 2012; 12:14. PMC: 3443418. DOI: 10.1186/1471-2342-12-14. View

2.
Min J, Lin F, Gidseg D, Weinsaft J, Berman D, Shaw L . Determinants of coronary calcium conversion among patients with a normal coronary calcium scan: what is the "warranty period" for remaining normal?. J Am Coll Cardiol. 2010; 55(11):1110-7. DOI: 10.1016/j.jacc.2009.08.088. View

3.
Puri R, Nicholls S, Shao M, Kataoka Y, Uno K, Kapadia S . Impact of statins on serial coronary calcification during atheroma progression and regression. J Am Coll Cardiol. 2015; 65(13):1273-1282. DOI: 10.1016/j.jacc.2015.01.036. View

4.
Friedewald V, Ambrose J, Stone G, Roberts W, Willerson J . The editor's roundtable: the vulnerable plaque. Am J Cardiol. 2008; 102(12):1644-53. DOI: 10.1016/j.amjcard.2008.09.001. View

5.
McEvoy J, Blaha M, DeFilippis A, Budoff M, Nasir K, Blumenthal R . Coronary artery calcium progression: an important clinical measurement? A review of published reports. J Am Coll Cardiol. 2010; 56(20):1613-22. DOI: 10.1016/j.jacc.2010.06.038. View